North America Diabetic Assays Market – Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Published Report
  • Dec 2019
  • North America
  • 350 Pages
  • No of Tables: 64
  • No of Figures: 35

By Type (Assays, Devices, Consumables), Disease Type (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), Deployment (Automated, Manual), End User (Hospitals, Clinics, Diagnostic Laboratories, Academic Institutes, Others), Distribution Channel (Direct, Indirect), Country (U.S., Canada, Mexico), Market Trends and Forecast to 2027.

Market Analysis and Insights: North America Diabetic Assays Market

North America diabetic assays market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with the CAGR of 4.5% in the forecast period of 2020 to 2027and expected to reach USD 1,707.90 million by 2027 from USD 1,218.84 million in 2019. Growing prevalence of diabetes are the factors for the market growth.

The prevalence of diabetes is more common these days due to poor life style, low immune system, family history, high blood pressure and absence of physical activities which leads to cardiovascular diseases, nerve damage, kidney damage, eye damage, slow healing, sleep apnea, Alzheimer's disease and others health problems.

For instance World Health Organization and United Nations has projected is 116.20% rise in geriatric population around the world by 2050 from 2017 and stated that each country in world will experience increase in population aged 60 years or above which is expected to increase demand for devices, consumables and assays for diabetes testing as American Diabetes Association (ADA) recommends that all diabetic patients requires to have their lipid profile determined yearly or at least assessment might be repeated every 2 years, diabetic assays are mandatory to perform any tests due to this reason increasing geriatric population is acting as a driver for global diabetic assays market.

This diabetic assays market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

North America Diabetic assays Market Scope and Market Size

North America diabetic assays market is segmented on the basis of type, disease type, deployment, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

On the basis of type, the market is segmented device, assays and consumables. In 2020, the assays segment is dominating and growing with the highest CAGR due to the advancement in the self-diagnostic procedure which enhances the ability to predict on time diabetes.

The advancement in assays such as quick identification of diabetes through blood samples major vendors augmented to the market growth of diabetes assays market. For instance,     in October 2019, Abbott (U.S.) and Tandem Diabetes Care, Inc (U.S.) developed integrated diabetes solutions that combine one of the leading technologies which are glucose sensing, manufactured by Abbott with innovative insulin delivery systems of Tandem in the order to provide more preferences for people to be able to manage their diabetes. The self-detection and monitoring of the diabetes and awareness towards the healthy life style penetrates the growth of the diabetes assays market.

On the basis of disease type, the market is segmented into type 1 diabetes, type 2 diabetes and gestational diabetes. In 2020, type 2 diabetes segments is dominating and growing in the North America diabetic assays market as the occurrence of type 2 diabetes are more which accounts for more than 80% in American population.  For instance, according to Centers for Disease Control and Prevention (CDC), in 2018, the total diabetes cases accounts around 30 million in total American population in which 90 to 95% of population due to unhealthy routine around 75% of younger population in American region is close to type 2 diabetes.

On the basis of deployment, the market is segmented into automated and manual. In 2020, automated segment is dominating and growing with the highest CAGR because of the new development of analysers and associated software which provides automated operational workflow while diagnosis procedure.

On the basis of end-user, the market is segmented into hospitals, clinics, diagnostic laboratories, academic institutes and others. In 2020, hospitals segment is dominating as well as growing in the market as the diabetes assays due to the wide availability of diagnostic procedures of diabetes in hospitals laboratories which is performed under trained professionals for analysis of blood glucose level of diabetic patient.

On the basis of distribution channel, the market is segmented into direct and indirect. In 2020, the direct segment is dominating the North America diabetic assays market and is growing with the highest CAGR as the hospitals, established diagnostic laboratories and among others prefer the product supply directly from the manufacturers as the offering through this mode are lower in cost and are at discounted prices. Further, massive supply of such product is directly maintained by the manufacturer itself and due to these reasons this segment is leading in the forecasted period.

Diabetic Assays Market Country Level Analysis

North America diabetic assays market is analysed and market size information is provided by country, by type, disease type, deployment, end user and distribution channel as referenced above.

The countries covered in the diabetic assays market report are U.S., Canada and Mexico in North America.

Country Level Analysis, By Type

North America dominates the diabetic assays market as the U.S. is leader in diabetic assays manufacturing and major leaders are generating revenue from the U.S. due to high prevalence cases of diabetes in the U.S. population requires high detection of diabetes assays for the identification and detection of diabetes diseases. For instance, in 2017, United Nation projected that 1 out of 5 diabetes patients are above 65 years old. Growing diabetes cases among geriatric population in the U.S. is leading the dominance of North America in diabetic assays market.   

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growing awareness towards the Detection of Diabetes and New Technology Penetration

Diabetic assays market also provides you with detailed market analysis for every country growth in automotive industry with diabetic assays sales, components sales, impact of technological development in assays and changes in regulatory scenarios with their support for the diabetic assays market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Diabetic Assays Market Share Analysis

Diabetic assays market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to North America diabetic assays market.

The major players covered in the report are Abbott, Danaher, Merck KGaA, SIEMENS HEALTHINEERS AG, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., EKF Diagnostics, DRG INSTRUMENTS GMBH, PTS Diagnostics, Ortho Clinical Diagnostics, Medipan GmbH, Diagnostic Automation/Cortez Diagnostics Inc., Diazyme Laboratories, Inc., Ethos Biosciences, Inc., BioAssay Systems, Tosoh Corporation, Abnova Corporation, Monobind Inc, ORGENTEC Diagnostika GmbH, ALPCO., among other domestic and regional players. Diabetic assays market share data is available for North America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product developments are also initiated by the companies worldwide which are also accelerating the North America diabetic assays market.

For instance,

  • In May 2018, Ortho Clinical Diagnostics, (U.S.) a global leader in in-vitro diagnostics, announced the launch of Ortho's VITROS Immunodiagnostic Products C-peptide Reagent Kit and Calibrators, which broadens the company's array of testing for all types of diabetes and other pancreatic disorders. The check is now commercially available in the United States and countries that accept the CE marking. This development will enhance the product portfolio of the company.
  • In April 2017, PTS Diagnostics (U.S.) received the FDA 510(k) Clearance in the U.S. for Extended HDL Range Lipid Panel Test Strips which will provide measurement range of 20 to 120 mg/dL (0.52 to 3.1 mmol/L) for HDL. Through this approval, the company will be able to meet the customer demand globally.

Partnership, joint ventures and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for diabetic assays through expanded model range.

Customization Available : North America Diabetic Assays Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

TABLE 1 CANADA REIMBURSEMENT LIMITS FOR TEST STRIPS FOR EACH 365-DAY PERIOD

TABLE 2 IRELAND REIMBURSEMENT FOR TEST STRIPS

TABLE 3 COMPARISON OF NGSP-CERTIFIED A1C POC DEVICES

TABLE 4 MEDICAL DEVICE RECALLS

TABLE 5 BIO-RAD LABORATORIES, INC. (U.S.) DIABETIC ASSAYS PRICES

TABLE 6 PRIVATE-SECTOR R&D INVESTMENT IN MEDICAL DEVICES AND EQUIPMENT ( IN USD MILLION)

TABLE 7 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 8 DIRECT COSTS OF DIABETES (IN USD)

TABLE 9 NORTH AMERICA DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 10 NORTH AMERICA ASSAYS DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 11 NORTH AMERICA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 12 NORTH AMERICA DEVICES IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 13 NORTH AMERICA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018–2027 (USD MILLION)

TABLE 14 NORTH AMERICA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 15 NORTH AMERICA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE,  2018–2027 (USD MILLION)

TABLE 16 NORTH AMERICA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 17 NORTH AMERICA TYPE 2 DIABETES DIABETIC ASSAYS MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 18 NORTH AMERICA TYPE 1 DIABETES IN DIABETIC ASSAYS MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 19 NORTH AMERICA GESTATIONAL DIABETES IN DIABETIC ASSAYS MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 20 NORTH AMERICA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 21 NORTH AMERICA AUTOMATED IN DIABETIC ASSAYS MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 22 NORTH AMERICA MANUAL IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 23 NORTH AMERICA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 24 NORTH AMERICA HOSPITALS IN DIABETIC ASSAYS MARKET, BY REGION,  2018-2027 (USD MILLION)

TABLE 25 NORTH AMERICA DIAGNOSTIC LABORATORIES IN DIABETIC ASSAYS MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 26 NORTH AMERICA CLINICS IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 27 NORTH AMERICA ACADEMIC INSTITUTES IN DIABETIC ASSAYS MARKET,  BY REGION, 2018-2027 (USD MILLION)

TABLE 28 NORTH AMERICA OTHERS IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 29 NORTH AMERICA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL,  2018-2027 (USD MILLION)

TABLE 30 NORTH AMERICA DIRECT IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 31 NORTH AMERICA INDIRECT IN DIABETIC ASSAYS MARKET, BY REGION, 2018-2027 (USD MILLION)

TABLE 32 NORTH AMERICA DIABETIC ASSAYS MARKET, BY COUNTRY, 2018-2027 (USD MILLION)

TABLE 33 NORTH AMERICA DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 34 NORTH AMERICA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 35 NORTH AMERICA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 36 NORTH AMERICA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 37 NORTH AMERICA DIABETIC ASSAYS MARKET, BY DISEASE TYPE,  2018-2027 (USD MILLION)

TABLE 38 NORTH AMERICA DIABETIC ASSAYS MARKET, BY DEPLOYMENT,  2018-2027 (USD MILLION)

TABLE 39 NORTH AMERICA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 40 NORTH AMERICA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 41 U.S. DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 42 U.S. DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 43 U.S. ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 44 U.S. CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 45 U.S. DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 46 U.S. DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 47 U.S. DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 48 U.S. DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)

TABLE 49 CANADA DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 50 CANADA DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 51 CANADA ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 52 CANADA CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 53 CANADA DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 54 CANADA DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 55 CANADA DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 56 CANADA DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL,  2018-2027 (USD MILLION)

TABLE 57 MEXICO DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 58 MEXICO DEVICES IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 59 MEXICO ASSAYS IN DIABETIC ASSAYS MARKET, BY TYPE, 2018-2027 (USD MILLION)

TABLE 60 MEXICO CONSUMABLES IN DIABETIC ASSAYS MARKET, BY TYPE,  2018-2027 (USD MILLION)

TABLE 61 MEXICO DIABETIC ASSAYS MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)

TABLE 62 MEXICO DIABETIC ASSAYS MARKET, BY DEPLOYMENT, 2018-2027 (USD MILLION)

TABLE 63 MEXICO DIABETIC ASSAYS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 64 MEXICO DIABETIC ASSAYS MARKET, BY DISTRIBUTION CHANNEL,  2018-2027 (USD MILLION)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions